LSL Pharma Group Inc.
LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. The company offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, and natural health … Read more
Market Cap & Net Worth: LSL Pharma Group Inc. (LSL)
LSL Pharma Group Inc. (V:LSL) has a market capitalization of $34.18 Million (CA$49.09 Million) as of March 19, 2026. Listed on the V stock exchange, this Canada-based company holds position #24632 globally and #124 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LSL Pharma Group Inc.'s stock price CA$0.41 by its total outstanding shares 121220176 (121.22 Million).
LSL Pharma Group Inc. Market Cap History: 2023 to 2026
LSL Pharma Group Inc.'s market capitalization history from 2023 to 2026. Data shows change from $40.93 Million to $34.18 Million (-18.33% CAGR).
LSL Pharma Group Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LSL Pharma Group Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.95x
LSL Pharma Group Inc.'s market cap is 1.95 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
10.43x
LSL Pharma Group Inc.'s market cap is 10.43 times its annual earnings
10.35x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $40.93 Million | $10.03 Million | -$8.47 Million | 4.08x | N/A |
| 2024 | $34.60 Million | $17.75 Million | $3.32 Million | 1.95x | 10.43x |
Competitor Companies of LSL by Market Capitalization
Companies near LSL Pharma Group Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to LSL Pharma Group Inc. by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
LSL Pharma Group Inc. Historical Marketcap From 2023 to 2026
Between 2023 and today, LSL Pharma Group Inc.'s market cap moved from $40.93 Million to $ 34.18 Million, with a yearly change of -18.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$34.18 Million | +15.71% |
| 2025 | CA$29.54 Million | -14.63% |
| 2024 | CA$34.60 Million | -15.46% |
| 2023 | CA$40.93 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of LSL Pharma Group Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $34.18 Million USD |
| MoneyControl | $34.18 Million USD |
| MarketWatch | $34.18 Million USD |
| marketcap.company | $34.18 Million USD |
| Reuters | $34.18 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.